Cargando…

Hyperhomocysteinemia as a Risk Factor for Vascular Contributions to Cognitive Impairment and Dementia

Behind only Alzheimer’s disease, vascular contributions to cognitive impairment and dementia (VCID) is the second most common cause of dementia, affecting roughly 10–40% of dementia patients. While there is no cure for VCID, several risk factors for VCID, such as diabetes, hypertension, and stroke,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Price, Brittani R., Wilcock, Donna M., Weekman, Erica M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6220027/ https://www.ncbi.nlm.nih.gov/pubmed/30429785 http://dx.doi.org/10.3389/fnagi.2018.00350

Ejemplares similares

Pathologic sequelae of vascular cognitive impairment and dementia sheds light on potential targets for intervention
por: Linton, Alexandria E., et al.
Publicado: (2021)

Hyperhomocysteinemia-Induced Gene Expression Changes in the Cell Types of the Brain
por: Weekman, Erica M., et al.
Publicado: (2017)

β-amyloid deposition is shifted to the vasculature and memory impairment is exacerbated when hyperhomocysteinemia is induced in APP/PS1 transgenic mice
por: Sudduth, Tiffany L, et al.
Publicado: (2014)

Atorvastatin rescues hyperhomocysteinemia-induced cognitive deficits and neuroinflammatory gene changes
por: Weekman, Erica M., et al.
Publicado: (2023)

Therapeutic Trem2 activation ameliorates amyloid-beta deposition and improves cognition in the 5XFAD model of amyloid deposition
por: Price, Brittani R., et al.
Publicado: (2020)

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia
por: Liu, Qing, et al.
Publicado: (2017)

Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events
por: Weekman, Erica M., et al.
Publicado: (2019)

Speech biomarkers of risk factors for vascular dementia in people with mild cognitive impairment
por: Martínez-Nicolás, Israel, et al.
Publicado: (2022)

Cholesterol, Atherosclerosis, and APOE in Vascular Contributions to Cognitive Impairment and Dementia (VCID): Potential Mechanisms and Therapy
por: Duong, Michael Tran, et al.
Publicado: (2021)

Vascular cognitive impairment and dementia: An early career researcher perspective
por: Silva, Nárlon C. Boa Sorte, et al.
Publicado: (2022)

Puerarin Alleviates Vascular Cognitive Impairment in Vascular Dementia Rats
por: Zhu, Tiantian, et al.
Publicado: (2021)

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia
por: Uemura, Maiko T., et al.
Publicado: (2020)

Genetic expression changes and pathologic findings associated with hyperhomocysteinemia in human autopsy brain tissue
por: Weekman, Erica M., et al.
Publicado: (2022)

Editorial: Modulation of neuroimmune systems to preserve brain function in aging and dementia
por: Braun, David J., et al.
Publicado: (2022)

Mechanisms of ARIA: is it time to focus on the unique immune environment of the neurovascular unit?
por: Foley, Kate E., et al.
Publicado: (2023)

White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities
por: Alber, Jessica, et al.
Publicado: (2019)

Hyperhomocysteinemia, Suppressed Immunity, and Altered Oxidative Metabolism Caused by Pathogenic Microbes in Atherosclerosis and Dementia
por: McCully, Kilmer S.
Publicado: (2017)

MicroRNA-210-5p Contributes to Cognitive Impairment in Early Vascular Dementia Rat Model Through Targeting Snap25
por: Ren, Zhenxing, et al.
Publicado: (2018)

Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
por: Lin, Yufeng, et al.
Publicado: (2018)

Cobalamin deficiency, hyperhomocysteinemia, and dementia
por: Werder, Steven F
Publicado: (2010)

Disrupted Brain Structural Connectivity Network in Subcortical Ischemic Vascular Cognitive Impairment With No Dementia
por: Sang, Linqiong, et al.
Publicado: (2020)

Corrigendum: Evaluation of Metformin on Cognitive Improvement in Patients With Non-dementia Vascular Cognitive Impairment and Abnormal Glucose Metabolism
por: Lin, Yufeng, et al.
Publicado: (2018)

The role of endothelial TRP channels in age-related vascular cognitive impairment and dementia
por: Negri, Sharon, et al.
Publicado: (2023)

Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors
por: Lecordier, Sarah, et al.
Publicado: (2021)

The Effect of Hyperhomocysteinemia on Motor Symptoms, Cognitive Status, and Vascular Risk in Patients with Parkinson's Disease
por: Kocer, Bilge, et al.
Publicado: (2016)

Changes in Blood Factors and Ultrasound Findings in Mild Cognitive Impairment and Dementia
por: Cho, Kyoungjoo, et al.
Publicado: (2017)

Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer’s Disease
por: Hess, Nicole C. L., et al.
Publicado: (2017)

Neuropsychological Decline Stratifies Dementia Risk in Cognitively Unimpaired and Impaired Older Adults
por: Ho, Jean K., et al.
Publicado: (2022)

Commentary: Cerebellar atrophy and its contribution to cognition in frontotemporal dementias
por: Ibáñez, Agustín, et al.
Publicado: (2018)

Corrigendum: Changes in Blood Factors and Ultrasound Findings in Mild Cognitive Impairment and Dementia
por: Cho, Kyoungjoo, et al.
Publicado: (2018)

Sex Differences in Demographic and Pharmacological Factors in Alzheimer Patients With Dementia and Cognitive Impairments
por: Coker-Ayo, Oreoluwa O., et al.
Publicado: (2022)

Menopause causes metabolic and cognitive impairments in a chronic cerebral hypoperfusion model of vascular contributions to cognitive impairment and dementia
por: Gannon, Olivia J., et al.
Publicado: (2023)

Genetic knockout of myosin light chain kinase (MLCK210) prevents cerebral microhemorrhages and attenuates neuroinflammation in a mouse model of vascular cognitive impairment and dementia
por: Braun, David J., et al.
Publicado: (2019)

Efficacy of acupuncture and pharmacological therapies for vascular cognitive impairment with no dementia: a network meta-analysis
por: Li, Ruiyu, et al.
Publicado: (2023)

Reduced biophotonic activities and spectral blueshift in Alzheimer’s disease and vascular dementia models with cognitive impairment
por: Wang, Zhuo, et al.
Publicado: (2023)

Incidence of Mild Cognitive Impairment and Dementia in Parkinson’s Disease: The Parkinson’s Disease Cognitive Impairment Study
por: Nicoletti, Alessandra, et al.
Publicado: (2019)

The Dose-Dependent Effects of Vascular Risk Factors on Dynamic Compensatory Neural Processes in Mild Cognitive Impairment
por: Chen, Haifeng, et al.
Publicado: (2018)

Aggregation of Vascular Risk Factors Modulates the Amplitude of Low-Frequency Fluctuation in Mild Cognitive Impairment Patients
por: Zhuang, Liying, et al.
Publicado: (2020)

Risk of Dementia or Cognitive Impairment in Sepsis Survivals: A Systematic Review and Meta-Analysis
por: Lei, Siyuan, et al.
Publicado: (2022)

Systemic and Disease-Specific Risk Factors in Vascular Dementia: Diagnosis and Prevention
por: Jaul, Efraim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6q9gqsmla66ks79gtgkjh1q2k1